CHONQUER, NCT06127407: Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen |
|
|
| Not yet recruiting | 3 | 136 | NA | Ivosidenib 500mg, Placebo | Servier Bio-Innovation LLC, Institut de Recherches Internationales Servier | Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen | 12/26 | 04/31 | | |
